Parmaceutical Raw Material 99% Protonitazene ISO 119276-01-6 For Research Chemical

Place of Origin CHINA
Brand Name XRD
Certification GMP
Model Number 119276-01-6
Minimum Order Quantity negotiable
Price Inquiry for Negotiable
Packaging Details 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require
Delivery Time 1-2days after payment received
Payment Terms T/T, Western Union,Bitcoin
Supply Ability 5000kg/year

Contact me for free samples and coupons.

Whatsapp:0086 18588475571

Wechat: 0086 18588475571

Skype: sales10@aixton.com

If you have any concern, we provide 24-hour online help.

x
Product Details
Cas No. 119276-01-6 Other Names Protonitazene
Product NamRopivacainee Protonitazene Appearance Yellow Powder
Assay 99% Protonitazene Grade Pharmaceutical Grade
Storage Cool Dried Storage Application Pharmaceutical Raw Intermediates
Leave a Message
Product Description

Parmaceutical Raw Material 99% Protonitazene ISO 119276-01-6 For Research Chemical

 

Basic Information:


Protonitazene Hydrochloride
CAS: 119276-01-6
Molecular formula: C23H30N4O3

GENERAL INFORMATION IUPAC Name: N,N-diethyl-2-[5-nitro-2-[(4-propoxyphenyl)methyl]benzimidazol-1- yl]ethanamine InChI String: InChI=1S/C23H30N4O3/c1-4-15-30-20-10-7-18(8-11-20)16-23-24-21- 17-19(27(28)29)9-12-22(21)26(23)14-13-25(5-2)6-3/h7-12,17H,4-6,13- 16H2,1-3H3 CFR: Not Scheduled (05/2021) CAS# 119276-01-6 Synonyms: Pronitazene, Propoxynitazene Source: NMS Labs - Toxicology Department


Description:
Product Name: Protonitazene (hydrochloride)
Synonyms: Protonitazene (hydrochloride);Protonitazene
CAS: 119276-01-6
MF: C23H30N4O3
MW: 410.5
Molecular Ion [M+ 410
Exact Mass [M+H]+ 411.2391
Mol File: Mol File

Protonitazene is classified as a novel opioid of the benzimidazole sub-class and is structurally dissimilar from fentan. Novel opioids have been reported to cause psychoactive effects similar to heroi, fentan, and other opioids. Novel opioids have also caused adverse events, including death, as described in the literature. Structurally similar compounds include etonitazen, metonitazen.iso , Etonitazen and structurally related synthetic opioids were first synthesized and reported in the literature in the 1950s.1 Data suggest that this group of analogues can have potency similar to or greater than fentan.2 Recent in vitro data suggest that protonitazene is more potent than fentan.3 Protonitazene is not explicitly scheduled in the United States; however, etonitazen and iso are Schedule I substances. Protonitazene and iso are isomeric analogues, sharing the same molecular formula and mass. Increased specificity is required to distinguish these two drugs during analytical testing (e.g., retention time, fragmentation pattern).


Storage:
The storeroom is ventilated and dried at low temperatures.

 

 

 

Parmaceutical Raw Material 99% Protonitazene ISO 119276-01-6 For Research Chemical 0

 

 

 

Packing:

 

1

 

Parmaceutical Raw Material 99% Protonitazene ISO 119276-01-6 For Research Chemical